Thomas G Lynch - Net Worth and Insider Trading
Thomas G Lynch Net Worth
The estimated net worth of Thomas G Lynch is at least $1 dollars as of 2024-11-13. Thomas G Lynch is the Director of Evofem Biosciences Inc and owns about 93 shares of Evofem Biosciences Inc (EVFM) stock worth over $1. Details can be seen in Thomas G Lynch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas G Lynch has not made any transactions after 2018-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas G Lynch
Thomas G Lynch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas G Lynch owns 2 companies in total, including Evofem Biosciences Inc (EVFM) , and GW Pharmaceuticals PLC (GWPH) .
Click here to see the complete history of Thomas G Lynch’s form 4 insider trades.
Insider Ownership Summary of Thomas G Lynch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EVFM | Evofem Biosciences Inc | 2018-08-15 | director |
| GWPH | GW Pharmaceuticals PLC | 2019-03-01 | director |
Thomas G Lynch Latest Holdings Summary
Thomas G Lynch currently owns a total of 1 stock. Thomas G Lynch owns 93 shares of Evofem Biosciences Inc (EVFM) as of August 15, 2018, with a value of $1.
Latest Holdings of Thomas G Lynch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EVFM | Evofem Biosciences Inc | 2018-08-15 | 93 | 0.01 | 1 |
Holding Weightings of Thomas G Lynch
Thomas G Lynch Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas G Lynch has made a total of 0 transactions in Evofem Biosciences Inc (EVFM) over the past 5 years. The most-recent trade in Evofem Biosciences Inc is the acquisition of 53 shares on August 15, 2018, which cost Thomas G Lynch around $226,000.
Insider Trading History of Thomas G Lynch
- 1
Thomas G Lynch Trading Performance
GuruFocus tracks the stock performance after each of Thomas G Lynch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas G Lynch is 53.18%. GuruFocus also compares Thomas G Lynch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas G Lynch within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas G Lynch's insider trading performs compared to the benchmark.
Performance of Thomas G Lynch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 65.91 | | | | | |
| Relative Return to S&P 500(%) | 62.84 | | | | | |
Thomas G Lynch Ownership Network
Ownership Network List of Thomas G Lynch
Ownership Network Relation of Thomas G Lynch
Thomas G Lynch Owned Company Details
What does Evofem Biosciences Inc do?
Who are the key executives at Evofem Biosciences Inc?
Thomas G Lynch is the director of Evofem Biosciences Inc. Other key executives at Evofem Biosciences Inc include Chief Financial Officer Yan Zhang , director & 10 percent owner Kim P. Kamdar , and Chief Commercial Officer Atkinson Katherine Cocca .
Evofem Biosciences Inc (EVFM) Insider Trades Summary
Over the past 18 months, Thomas G Lynch made no insider transaction in Evofem Biosciences Inc (EVFM). Other recent insider transactions involving Evofem Biosciences Inc (EVFM) include a net sale of 104 shares made by Yan Zhang , and a net sale of 10 shares made by Kim P. Kamdar .
In summary, during the past 3 months, insiders sold 0 shares of Evofem Biosciences Inc (EVFM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114 shares of Evofem Biosciences Inc (EVFM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114 shares.
Evofem Biosciences Inc (EVFM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evofem Biosciences Inc Insider Transactions
Thomas G Lynch Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas G Lynch. You might contact Thomas G Lynch via mailing address: C/o Evofem Biosciences, Inc., 12400 High Bluff Drive, Suite 600, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
